NC100150
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Five types of superparamagnetic iron oxide (SPIO), i.e. Ferumoxides (Feridex(®) IV, Berlex Laboratories), Ferucarbotran (Resovist…
The purpose of this study was to determine the cellular distribution and degradation in rat liver following intravenous injection…
To investigate the duration of liver R2* enhancement and pharmacokinetics following administration of an iron oxide nanoparticle…
To investigate the physiological origins responsible for the varying blood oxygenation level dependent (BOLD) magnetic resonance…
PURPOSE
To define the diagnostic potential of magnetic resonance (MR) imaging enhanced with ultrasmall superparamagnetic iron…
A preparation of monocrystalline iron oxide nanoparticles with an oxidized starch coating, currently in clinical trials (NC100150…
In this Phase I clinical study, a novel ultrasmall superparamagnetic iron oxide contrast agent, NC100150 Injection (Nycomed…
Recent developments of novel magnetic resonance intravascular contrast agents with low T1 in blood and a long intravascular half…
A new ultrasmall superparamagnetic iron oxide (Clariscan; NC100150 Injection) was studied in domestic farm pigs. The T1 effects…